Anteilseigner
Benjamin Shapiro (4,85 %) BML Capital Management LLC (3,13 %) Boothbay Fund Management LLC (1,30 %) Jess S. Morgan & Co., Inc. (0,91 %) Renaissance Technologies LLC (0,85 %) Rathbones Investment Management Ltd. (0,72 %) Two Sigma Advisers LP (0,70 %) Merrill Lynch International (Investment Management) (0,62 %) Two Sigma Investments LP (0,39 %) Michael Rabinowitz (0,31 %) KSM Mutual Funds Ltd. (0,31 %) Squarepoint OPS LLC (0,29 %)
Kontakt
Oramed Pharmaceuticals Inc.
2 Elza Street
93706 Jerusalem